Notice: Function is_search was called incorrectly. Conditional query tags do not work before the query is run. Before then, they always return false. Please see Debugging in WordPress for more information. (This message was added in version 3.1.0.) in /var/www/staging/nav_timebull/wp-includes/functions.php on line 6131

Notice: Function is_404 was called incorrectly. Conditional query tags do not work before the query is run. Before then, they always return false. Please see Debugging in WordPress for more information. (This message was added in version 3.1.0.) in /var/www/staging/nav_timebull/wp-includes/functions.php on line 6131
Stock Market: Investors can track this IPO, it can be profitable in 2025 – Times Bull

Stock Market: Investors can track this IPO, it can be profitable in 2025

by
Stock market

Stock Market: On Monday, Senores Pharmaceuticals shares debuted at Rs 600 on the NSE and Rs 593.70 on the BSE, reflecting a 53 percent premium. Its initial public offering began on December 20, 2024, and concluded on December 24, 2024. The subscription status and grey market premium suggested significant listing increases for Senores Pharmaceuticals’ stock price. 

Some important informations about Senores Pharmaceuticals IPO

Senores Pharmaceuticals IPO garnered a subscription of 97.86 times, with 93.16 times in the retail segment, 97.84 times in the QIB segment, and 100.35 times in the NII segment. The grey market premium (GMP) for Senores Pharmaceuticals IPO was at +284. This indicated that Senores Pharmaceuticals’ shares were priced at Rs 284 more than the issue price in the grey market.

An important thing: according to those numbers what is the indication in the market ?

This indicated that market participants anticipated Senores Pharmaceuticals shares would list at Rs 675, which is 72.63 percent above the issue price.

The price range for Senores Pharmaceuticals IPO…

The price range for Senores Pharmaceuticals IPO was set between Rs 372 and Rs 391 per share, and the share listing occurred significantly above the upper price range of the issue price. The IPO of Senores Pharmaceuticals was a book-built offering of Rs 582.11 crore. The matter involved a new issuance of 1.28 crore shares totaling Rs 500 crore and a sale offer of 0.21 crore shares amounting to Rs 82.11 crore. 

But it is important to remember what the experts have said. It is believed that the past numbers may not always meet the expectations or project numbers in the near future. To make any kind of investment in any stocks, investors need to study well and observe their desired company’s performance in the stock market keenly.

Disclaimer : For any financial invest anywhere on your own responsibility, Times Bull will not be responsible for it.

Share.